A federal appeals court, in a decision unsealed Wednesday, upheld the dismissal of a whistleblower lawsuit against Johnson & Johnson as a sanction for the plaintiffs’ misuse of confidential records they obtained through related litigation.
https://www.pharmalive.com/wp-content/uploads/2023/02/ReutersJNJ2-21-2023.jpg8001200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-06-02 06:48:552023-06-02 10:46:05J&J secures dismissal of whistleblower case over misuse of confidential info
